Recruiting

Observational Study

Sponsor:

GE Healthcare

Code:

NCT03856450

Conditions

Distal Radius Fracture

Scaphoid Fracture

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

DTS

X-ray

MRI or CT

Study Details

Brief summary:

The study described herein is being conducted to collect clinical data associated with diagnosis and treatment information using the VolumeRAD advanced application.

Conditions

Distal Radius Fracture

Scaphoid Fracture

Study ID

NCT03856450

Start date

Dec 20, 2018

Status verified date

Sep, 2020

Completion date

Sep 1, 2021

Anticipated

Primary completion date

Sep 1, 2021

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria for Control-arm Subjects:

Subjects who meet all of the following inclusion criteria may be enrolled in this study:

1. Are adults aged 18 years or older;
2. Are able and willing to comply with study procedures; and
3. Are able and willing to provide written informed consent to participate in this study.

Exclusion Criteria for Control-arm Subjects:

Subjects who meet any of the following exclusion criteria will be excluded from this study:

1. Are documented as pregnant based on PI's medical judgment and in consideration of local clinical practice standards for evidence of pregnancy;
2. Have had known prior trauma in either wrist.

Inclusion Criteria for Test-arm Subjects:

Subjects who meet all of the following inclusion criteria may be enrolled in this study:

1. Are adults aged 18 years or older;
2. Have a confirmed or suspected distal radius or scaphoid wrist fracture;
3. Have completed an X-ray imaging exam per standard of care;
4. Have a standard of care (SOC) CT or MRI exam ordered;
5. Are able and willing to complete DTS imaging exam (if not already completed);
6. Are able and willing to comply with study procedures; and
7. Are able and willing to provide written informed consent to participate in this study.

Exclusion Criteria for Test-arm Subjects:

Subjects who meet any of the following exclusion criteria will be excluded from this study:

1. Are documented as pregnant based on PI's medical judgment and in consideration of local clinical practice standards for evidence of pregnancy;
2. Have additional trauma within the image field of view that either impacts the visualization or changes the treatment of the scaphoid or distal radius fracture;
3. Have had prior reconstructive surgery or fixation in the wrist.

Study Design

Enrollment

140 participants

Anticipated

Allocation

Non randomized

Intervention Model

Single group

Primary purpose

Diagnostic

Interventions and Outcome Measures

Arms

active comparator: Control-arm group

The control-arm group will consist of healthy volunteers with no known prior trauma in the wrists. The diagnostic truth for subjects in the control-arm will be no fracture and the treatment truth will be no treatment.

experimental: Test-arm group

The test-arm group will consist of subjects who present with a wrist injury and initial SOC X-ray imaging results show a confirmed or suspected distal radius or scaphoid fracture, for which additional diagnostic imaging shall be ordered. Diagnostic truth for subjects in the test-arm will be the per-subject clinical diagnosis and the treatment truth will be the per-subject treatment received.

Interventions

DTS

Subjects undergo wrist imaging using DTS.

X-ray

Subjects undergo wrist imaging using standard X-ray imaging.

MRI or CT

Subjects may undergo wrist imaging using MRI or CT.

Primary outcome measure

  • Number of X-ray Images [ Time Frame: 1 year ]
  • Number of DTS images [ Time Frame: 1 year ]
  • Number of CT (or MRI) images [ Time Frame: 1 year ]

Central Contacts and Locations

Locations

University of Pennsylvania Hospital - Department of Orthopaedic Surgery

Recruiting

Philadelphia, Pennsylvania, United States, 19104

Contacts

More Information

Sponsor

GE Healthcare

Last update posted

Sep 30, 2020

Last verified

Sep, 2020

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by GE Healthcare on 2020-09-30.